Flecainide in the intrauterine treatment of fetal supraventricular tachycardia

Ultrasound in Obstetrics and Gynecology

Volumn 19, Issue 2, 2002, Pages 158-164

  Krapp, M ^a   Baschat, A A ^b   Gembruch, U ^a   Geipel, A ^a   Germer, U ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

Antiarrhythmic drug; Ductus venosus; Fetal arrhythmia; Flecainide; Hydrops fetalis; Inferior vena cava; Supraventricular tachycardia; Venous Doppler

Indexed keywords

DIGOXIN; FLECAINIDE;

ARTICLE; ATRIOVENTRICULAR CONDUCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FETUS; FETUS HEART RATE; HUMAN; HYDROPS; PRIORITY JOURNAL; SINUS RHYTHM; SUPRAVENTRICULAR TACHYCARDIA; SURVIVAL; TREATMENT OUTCOME; VEIN BLOOD FLOW;

ANTI-ARRHYTHMIA AGENTS; CARDIOTOCOGRAPHY; DIGOXIN; FEMALE; FETAL DISEASES; FLECAINIDE; HUMANS; HYDROPS FETALIS; PREGNANCY; TACHYCARDIA, SUPRAVENTRICULAR; ULTRASONOGRAPHY, DOPPLER; ULTRASONOGRAPHY, PRENATAL;

EID: 0036128698     PISSN: 09607692     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0960-7692.2001.00562.x     Document Type: Article

References (27)

1. Fetal tachycardia: Mechanisms and predictors of hydrops fetalis
2. Changes of venous blood flow velocity waveforms in fetuses with supraventricular tachycardia
3. In utero treatment of fetal supraventricular tachycardia
4. Longitudinal study in 18 cases of fetal supraventricular tachycardia: Doppler-echocardiographic findings and pathophysiological implications
5. Obstetric importance, diagnosis, and management of fetal tachycardias
6. Fetal tachyarrhythmias: Transplacental and direct treatment of the fetus a report of sixty fetuses
7. Fetal tachycardias: Management and outcome of 127 consecutive cases
8. Fetal cardiac arrhythmias. Diagnosis and therapy
9. Fetal arrhythmia
10. Summary of efficacy and safety of flecainide for supraventricular arrhythmias
11. Flecainide in the treatment of fetal tachycardias
12. The efficacy of flecainide versus digoxin in the management of fetal supraventricular tachycardia
13. Venous blood flow pattern suggesting tachycardia-induced 'cardiomyopathy' in the fetus
14. Two dimensional echocardiographic diagnosis of situs
15. Venous Doppler in the sonographic surveillance of fetuses with supraventricular tachycardia
16. Management outcome and follow up of fetal tachycardia
17. Ventriculo-atrial time interval measured on M mode echocardiography: A determining element in diagnosis, treatment, and prognosis of fetal supraventricular tachycardia
18. Electrophysiological principles and fetal antiarrhythmic therapy
19. Repeated treatment with amiodarone in a fetus with refractory supraventricular tachycardia and hydrops fetalis
20. Fetal supraventricular tachycardia and hydrops fetalis: Combined intensive, direct, and transplacental therapy
21. Fetal supraventricular tachycardia complicated by hydrops fetalis: A role for direct fetal intramuscular therapy
22. Fetal death after successful conversion of fetal supraventricular tachycardia with digoxin and verapamil
23. Foetal supraventricular tachycardia treated with sotalol
24. Sotalol in the treatment of fetal dysrhythmias
25. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The cardiac arrhythmia suppression trial
26. Reversal of venous blood flow with atrial tachycardia and hydrops in fetal sheep
27. Neurological morbidity after fetal supraventricular tachyarrhythmia